Susan Hurst

Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction

Odette A. Fahmi, Susan Hurst, David R. Plowchalk et al. · Drug Metabolism and Disposition · 2009 · 212 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites

Deepak Dalvie, R. Scott Obach, Ping Kang et al. · Chemical Research in Toxicology · 2009 · 187 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans

Susan Hurst, Cho‐Ming Loi, Joanne Brodfuehrer et al. · Expert Opinion on Drug Metabolism & Toxicology · 2007 · 117 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Application of CYP3A4<i>in vitro</i>data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction

Kuresh Youdim, Aref Zayed, Maurice Dickins et al. · British Journal of Clinical Pharmacology · 2008 · 97 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model

Timothy P. LaBranche, Alison M. Bendele, Brian C Omura et al. · Annals of the Rheumatic Diseases · 2016 · 58 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16